Department of Cardiology, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China.
Mol Biol Rep. 2011 Apr;38(4):2371-6. doi: 10.1007/s11033-010-0370-1. Epub 2010 Nov 16.
Published data on the association between prothrombin G20210A polymorphism and coronary artery disease (CAD) risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. A total of 42 case-control studies including 15,041 cases and 21,507 controls were included in this meta-analysis. Overall, significantly elevated CAD risk was associated with prothrombin G20210A polymorphism (OR, 1.22; 95% CI 1.07-1.40; P=0.003) when 39 eligible studies were pooled into the meta-analysis. In the subgroup analysis, borderline statistically increased risk was found for myocardial infarction in 22 case-control studies (OR, 1.27; 95% CI 1.00-1.61; P=0.05). When stratified by ethnicity, significantly elevated risk was found in Europeans (OR, 1.19; 95% CI, 1.02-1.38; P=0.02). However, no statistical differences were found among Americans and Asians. In summary, this meta-analysis indicated that prothrombin G20210A allele is a low-penetrant risk factor for developing CAD in Europeans.
已发表的关于凝血酶原 G20210A 多态性与冠心病(CAD)风险之间关联的数据尚无定论。为了更准确地评估这种关系,进行了荟萃分析。这项荟萃分析共纳入了 42 项病例对照研究,包括 15041 例病例和 21507 例对照。总体而言,当将 39 项符合条件的研究纳入荟萃分析时,凝血酶原 G20210A 多态性与 CAD 风险显著升高相关(OR,1.22;95%CI,1.07-1.40;P=0.003)。在亚组分析中,在 22 项病例对照研究中发现心肌梗死的风险略有增加(OR,1.27;95%CI,1.00-1.61;P=0.05)。按种族分层时,在欧洲人群中发现风险显著升高(OR,1.19;95%CI,1.02-1.38;P=0.02)。然而,在美洲人和亚洲人中未发现统计学差异。总之,这项荟萃分析表明,凝血酶原 G20210A 等位基因是欧洲人发生 CAD 的低外显度风险因素。